SCHEMBL29198263

SCHEMBL29198263

CC(C)(C)OC(=O)N1CCC(n2c(=O)[nH]c3c(N)cccc32)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 2/20 0.49
HSD11B1 P28845 6/20 0.48
CHRM2 P08172 1/20 0.48
CHRM4 P08173 1/20 0.48
CHRM5 P08912 1/20 0.48
CHRM1 P11229 1/20 0.48
CHRM3 P20309 1/20 0.48
PRKCG P05129 1/20 0.44
PRKCB P05771 1/20 0.44
PRKCA P17252 1/20 0.44
PRKCH P24723 1/20 0.44
PRKCE Q02156 1/20 0.44
PRKCD Q05655 1/20 0.44
OPRM1 P35372 1/20 0.44
OPRD1 P41143 1/20 0.44
OGFRL1 Q5TC84 1/20 0.44
CTSD P07339 1/20 0.43
CTSE P14091 1/20 0.43
BACE1 P56817 1/20 0.43
GPR119 Q8TDV5 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28511175 0.88 CCR5 (0.50) CCR5HSD11B1CHRM2CHRM4CHRM5
SCHEMBL28510485 0.88 HSD11B1 (0.61) CCR5HSD11B1CHRM2CHRM4CHRM5
SCHEMBL28501201 0.87 HSD11B1 (0.50) CCR5HSD11B1CHRM2CHRM4CHRM5
SCHEMBL3246870 0.87 OPRM1 (0.55) CCR5HSD11B1CHRM2CHRM4CHRM5
SCHEMBL4234708 0.87 DRD2 (0.52) CCR5HSD11B1CHRM2CHRM4CHRM5
SCHEMBL22587856 0.86 HSD11B1 (0.56) CCR5HSD11B1CHRM2CHRM4CHRM5
SCHEMBL28505355 0.86 CCR5 (0.49) CCR5HSD11B1CHRM2CHRM4CHRM5
SCHEMBL22588035 0.85 HSD11B1 (0.53) CCR5HSD11B1CHRM2CHRM4CHRM5
SCHEMBL29198280 0.85 CCR5 (0.48) CCR5HSD11B1CHRM2CHRM4CHRM5
SCHEMBL29198208 0.85 CCR5 (0.48) CCR5HSD11B1CHRM2CHRM4CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112074511-B Substituted benzodiazoles and their use in therapy 托马斯·黑勒戴药物研究基金会 2024-04-26 CN disclosed